Search & Analyze
Popular Searches
Morepen Laboratories Ltd.
Healthcare₹53.883.62%
24 Jul, 4:01 PM
CMP₹53.88
Mkt Cap₹2.87K Cr
P/E30.29
P/B2.31
ROE11.78%
52W High₹64.57
52W Low₹33.44
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
30.29
P/B Ratio
2.31
EV/EBITDA
20.41
Price/Sales
1.59
Dividend Yield (%)
0.38
EPS (TTM ₹)
1.73
Book Value (₹)
22.75
ROE (%)
11.78
ROCE (%)
15.48
ROA (%)
7.69
EBITDA Margin (%)
9.61
Net Profit Margin (%)
6.51
Debt/Equity
0.07
Current Ratio
2.32
Interest Coverage
19.59
Asset Turnover
1.18
Working Capital/Sales
2.75
Core EBITDA Growth (%)
11.49
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 118805.64 | 154682.69 | 141753 | 169043.25 | 181157.58 |
| Net Sales | 118805.64 | 154682.69 | 141753 | 169043.25 | 181157.58 |
| Total Income | 120012.53 | 156692.57 | 142366.34 | 170440.33 | 182993.95 |
| Total Expenditure | 106954.23 | 141015.45 | 133799.69 | 153180.79 | 163750.55 |
| Operating Profit | 13058.3 | 15677.12 | 8566.65 | 17259.54 | 19243.4 |
| Depreciation | 3028.33 | 2764.25 | 2793.04 | 3346.95 | 2898.17 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 9851.15 | 12670.26 | 5575.53 | 13541.57 | 15510.94 |
| Tax | 142.15 | 2502.13 | 1707.98 | 3879.54 | 3709.4 |
| Profit After Tax (PAT) | 9709 | 10168.13 | 3867.55 | 9662.03 | 11801.54 |
| EPS (₹) | 2.16 | 2.26 | 0.77 | 1.88 | 2.2 |
| Dividend Payout % | — | — | — | — | 10 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 8995.86 | 9555.86 | 10222.71 | 10222.71 | 10958.41 |
| Reserves | 29104.12 | 45675.26 | 65068.1 | 74499.91 | 104664.66 |
| Shareholders Funds | 42474.98 | 57856.12 | 75290.81 | 84722.62 | 115623.07 |
| Total Debt | 1704.57 | 1856.9 | 2516.41 | 2899.92 | 7939.27 |
| Total Liabilities | 85814.6 | 107005.27 | 111049.51 | 129320.51 | 177809.93 |
| Total Assets | 85814.6 | 107005.27 | 111049.51 | 129320.51 | 177809.93 |
| Book Value / Share | 8.4706 | 11.5596 | 14.7301 | 16.5754 | 21.1022 |
| Assets | 85814.6 | 107005.27 | 111049.51 | 129320.51 | 177809.93 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 5082.57 | -6024.02 | -9117.06 | 7337.46 | 3205.67 |
| Investing Activities | -7035.07 | -3167.85 | -4650.93 | -8330.02 | -32150.66 |
| Financing Activities | 4727.28 | 6633.44 | 14354.31 | 520.49 | 29988.6 |
| Net Cash Flow | 2774.78 | -2558.43 | 586.32 | -472.07 | 1043.61 |
MOREPENLAB
₹53.88
+3.62%